Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma
Abstract Background Uveal melanoma (UM) is a rare but aggressive cancer, which is the most common primary intraocular malignancy in adults. We aimed to develop and validate a competing risk nomogram to predict cancer-specific survival (CSS) of patients with UM, as well as compare its prognostic valu...
Main Authors: | Qiaozhu Zeng, Yuou Yao, Mingwei Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-021-01968-6 |
Similar Items
-
Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012)
by: Mahendraraj K, et al.
Published: (2016-10-01) -
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
by: Luca Tagliaferri, et al.
Published: (2017-12-01) -
Nomogram application to predict overall and cancer-specific survival in osteosarcoma
by: Zheng W, et al.
Published: (2018-11-01) -
Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
by: Li Chen, et al.
Published: (2019-09-01) -
Epidemiology of uveal melanomas in Moscow
by: E. E. Grishina, et al.
Published: (2017-08-01)